Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine New Drug Application…
BRIDGEWATER, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Catheter Precision Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a…
STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…
RIYADH, Saudi Arabia, Feb. 09, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia’s King Faisal Specialist Hospital & Research Centre (KFSHRC) –…
NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global healthcare IT market size…
For the eleventh time, MRO outperforms the competition in every category for release ofinformation services and software in the 2025…
CereCore earns top ratings from clients, outperforms in loyalty pillar NASHVILLE, Tenn., Feb. 7, 2025 /PRNewswire/ -- CereCore®, a leading provider…
ROSEMONT, Ill., Feb. 7, 2025 /PRNewswire/ -- Nicolas S. Piuzzi, MD, was recognized as the 2025 Kappa Delta Young Investigator Award…
LOS ANGELES, Feb. 6, 2025 /PRNewswire/ -- Vitalacy, Inc., a leader in patient safety technology, is proud to announce the launch…
New leader plans to build on AVIA's strengths and to advance innovations CHICAGO, Feb. 6, 2025 /PRNewswire/ -- AVIA today…